AIM Clinical Science Fellow Grantee: Sylvanna Vargas, PhD, MPH - UCLA Geffen School of Medicine. Dr. Vargas's research aims to increase the quality and reach of mental health care, with an eye on improving services for the most vulnerable.
AIM Clinical Science Fellow Grantee: Madelaine R. Abel, PhD -Massachusetts General Hospital. Madelaine will evaluate the acceptability and efficacy of a single-session, self-guided, online intervention delivered to parents of children ages 5-12-years-old who are on the waitlist for outpatient CBT.
AIM Clinical Science Fellow Grant to Dr. Hannah Lawrence, from the Treatment and Etiology of Depression in Youth Laboratory at McLean Hospital/Harvard Medical School. Dr. Lawrence research will test whether a smartphone-delivered mindfulness intervention reduces anxiety and depressive symptoms in adolescents by helping them disengage from repetitive negative thought (RNT).
AIM Clinical Science Fellow Grant to Benjamin Johnson, from Pennsylvania State. Dr. Johnson’s research combines two aims: 1) apply machine learning to ecological momentary assessment (EMA) data to predict the emergence of self-harm urges and suicidality among young adults; 2) employ a mobile intervention to reduce the likelihood of such
AIM Clinical Science Fellow Grant to postdoctoral research associate, Alexandra Werntz, from the University of Virginia. Dr. Werntz will develop and evaluate a free, easy-to-access technology-delivered intervention (TDI) for youth anxiety used within the context of formal mentoring programs. $50,000
Two coordinated telehealth family intervention eating disorder studies at UCSD and Stanford The study will include two coordinated projects focused on the feasibility, acceptability, and preliminary clinical utility of telehealth to deliver family interventions for eating disorders in youth. The UCSD project will focus on multi-family support for patients in
Dr. Marc Weintraub examined the emotional and cognitive pathways linked to severe mental illness in adolescents. His findings include a new approach to treating early symptoms of severe mental illness in teens, holding promise for prevention.
$45,600 AIM grant. Dr. Adam Gazzaley, an AIM Scientific Advisory Board member and founder of UCSF’s Neuroscape, will conduct a pilot study of a novel, adaptive attention training software, Engage, in adolescents who have difficulties with attention.
Seed funding for a study of innovative treatment that combines computerized brain training exercises resembling popular video games and intensive “talk therapy.” The research is being done by Dr. Barbara Cornblatt, a Professor of Psychiatry and Molecular Medicine and the Director of the Recognition and Prevention (RAP) Program at Hofstra
